Alpha 2.0
Login Register
» Authors » Peter Norwood

Peter Norwood

Explore the profile of Peter Norwood including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 24
Followers 0
Related Specialties
General Medicine
Oncology
Molecular Biology
Top 10 Co-Authors
Mary Jane Rotheram-Borus
Jennifer Tseng
Judy C Boughey
Laura J Esserman
Dallas Swendeman
Elizabeth Mayfield Arnold
Elissa Price
A Jo Chien
Hope S Rugo
Marie Davidian
Published In
Vaccines (Basel)
Nat Med
Ann Surg Oncol
Sex Transm Dis
PLoS Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Adaptive randomization methods for sequential multiple assignment randomized trials (smarts) via thompson sampling
Norwood P, Davidian M, Laber E
Biometrics . 2024 Dec; 80(4). PMID: 39679738
Response-adaptive randomization (RAR) has been studied extensively in conventional, single-stage clinical trials, where it has been shown to yield ethical and statistical benefits, especially in trials with many treatment arms....
2.
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy
Jacob S, Christofferson A, Fisch S, Norwood P, Castillo P, Yu H, et al.
Breast Cancer Res Treat . 2024 Sep; 209(1):147-159. PMID: 39305392
Purpose: Establishing breast MRI imaging patterns associated with neoadjuvant immunotherapy is needed to monitor response. We analyzed serial breast MRIs in patients receiving neoadjuvant chemo-immunotherapy on the I-SPY2 clinical trial....
3.
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
Shatsky R, Trivedi M, Yau C, Nanda R, Rugo H, Davidian M, et al.
Nat Med . 2024 Sep; 30(12):3737-3747. PMID: 39277672
Sequential adaptive trial designs can help accomplish the goals of personalized medicine, optimizing outcomes and avoiding unnecessary toxicity. Here we describe the results of incorporating a promising antibody-drug conjugate, datopotamab-deruxtecan...
4.
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
Khoury K, Meisel J, Yau C, Rugo H, Nanda R, Davidian M, et al.
Nat Med . 2024 Sep; 30(12):3728-3736. PMID: 39277671
Among the goals of patient-centric care are the advancement of effective personalized treatment, while minimizing toxicity. The phase 2 I-SPY2.2 trial uses a neoadjuvant sequential therapy approach in breast cancer...
5.
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial
Switalla K, Boughey J, Dimitroff K, Yau C, Ladores V, Yu H, et al.
Ann Surg Oncol . 2024 Jul; 31(11):7249-7259. PMID: 38995451
Background: For patients with clinically node-positive (cN+) breast cancer undergoing neoadjuvant chemotherapy (NAC), retrieving previously clipped, biopsy-proven positive lymph nodes during sentinel lymph node biopsy [i.e., targeted axillary dissection (TAD)]...
6.
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial
Piltin M, Norwood P, Ladores V, Mukhtar R, Sauder C, Golshan M, et al.
Ann Surg Oncol . 2024 Jul; 31(11):7420-7428. PMID: 38980586
Background: Internal mammary lymphadenopathy (IML) plays a role in breast cancer stage and prognosis. We aimed to evaluate method of IML detection, how IML impacts response to neoadjuvant chemotherapy (NAC),...
7.
Factors Associated With Antiretroviral Adherence Among Youth Living With HIV
Arnold E, Kamal S, Rotheram-Borus M, Bridges S, Gertsch W, Norwood P, et al.
J Acquir Immune Defic Syndr . 2023 Nov; 95(3):215-221. PMID: 37977178
Background: Youth living with HIV (YLH) have an increased risk for psychosocial stressors that can affect their antiretroviral (ARV) adherence. We examined factors associated with self-reported ARV adherence among YLH...
8.
Using Machine Learning to Identify Predictors of Sexually Transmitted Infections Over Time Among Young People Living With or at Risk for HIV Who Participated in ATN Protocols 147, 148, and 149
Comulada W, Rotheram-Borus M, Arnold E, Norwood P, Lee S, Ocasio M, et al.
Sex Transm Dis . 2023 Aug; 50(11):739-745. PMID: 37643402
Background: Sexually transmitted infections (STIs) among youth aged 12 to 24 years have doubled in the last 13 years, accounting for 50% of STIs nationally. We need to identify predictors...
9.
Maternal depression, alcohol use, and transient effects of perinatal paraprofessional home visiting in South Africa: Eight-year follow-up of a cluster randomized controlled trial
Rotheram-Borus M, Tomlinson M, Worthman C, Norwood P, le Roux I, OConnor M
Soc Sci Med . 2023 Mar; 324:115853. PMID: 37001280
Background: South African mothers confront synergistic challenges from depression, alcohol use, and HIV/AIDS. The importance of maternal functioning for child development motivates interventions, yet long-term outcomes seldom are tracked. Furthermore,...
10.
The effect of supervision on community health workers' effectiveness with households in rural South Africa: A cluster randomized controlled trial
Rotheram-Borus M, le Roux K, Norwood P, Katzen L, Snyman A, le Roux I, et al.
PLoS Med . 2023 Mar; 20(3):e1004170. PMID: 36862754
Background: Community health workers (CHWs) can supplement professional medical providers, especially in rural settings where resources are particularly scarce. Yet, outcomes of studies evaluating CHWs effectiveness have been highly variable...